ArticleOncology letters2021

Pan-RAF inhibitor LY3009120 is highly synergistic with low-dose cytarabine, but not azacitidine, in acute myeloid leukemia with

Jihyun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.